RxDoctor Payments Data

Stephen Hoge, MD

Orthopaedic Surgery of the Spine · Shreveport, LANPI 1184010399

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (54.4%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Innovasis Inc accounts for 63.1% of it on its own, with 32 other manufacturers making up the rest. Reporting peaked in 2024 at $18,363 and has fallen 89.5% since, to $1,932 in 2025.

$48,301in general payments, 2019–2025

Across 173 payments — averaging $279.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Innovasis Inc$30K
  • Globus Medical$9K
  • Alphatec Spine, Inc$3K
  • Stryker$1K
  • Orthofix Medical, Inc.$426
  • Medtronic$369
  • plus $3K from 27 others

What the payments were for

  • Speaking & faculty fees$14,07529%
  • Travel & lodging$26,26854%
  • Food & beverage$7,93316%
  • Other$250%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$48,301 in reported general payments places this provider in the 80th percentile of 29 orthopaedic surgery of the spine providers in Louisiana.

See all orthopaedic surgery of the spine providers in Louisiana

Medicare billing

Part B allowed, 2024
$192,888
Medicare patients
373
Services billed
1,415

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin179$1,633
Cyclobenzaprine Hcl173$1,579
Lidocaine14$1,245
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen57$924
Pregabalin50$672
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen48$542
Methocarbamol25$331
Tramadol Hcl77$209
Meloxicam68$101
Amitriptyline Hcl18$47
Tizanidine Hcl17$41

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Shreveport

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →